CAN-2409 Receives FDA Orphan Drug Designation in Pancreatic Cancer

CAN-2409 has received orphan drug designation from the FDA for the treatment of patients with pancreatic cancer.

Related Keywords

Garrett Nichols ,Candel Therapeutics Inc , ,Candel Therapeutics ,Peter Tak ,Gastrointestinal Cancer ,News ,Metastatic Pancreatic Ductal Adenocarcinoma ,Pdac ,Can 2409 ,Valacyclovir ,